Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1989 May;83(5):1556–1562. doi: 10.1172/JCI114052

Pattern of cutaneous immunoglobulin G deposition in subacute cutaneous lupus erythematosus is reproduced by infusing purified anti-Ro (SSA) autoantibodies into human skin-grafted mice.

L A Lee 1, K K Gaither 1, S N Coulter 1, D A Norris 1, J B Harley 1
PMCID: PMC303861  PMID: 2651477

Abstract

Subacute cutaneous lupus and neonatal lupus are closely associated with the presence of anti-Ro (SSA) autoantibodies, but there is no direct evidence establishing a role for anti-Ro (SSA) in these diseases. After parental injection into mice, IgG from sera containing anti-Ro (SSA) will bind human skin grafted onto the mice. To determine whether the antibody binding is due to anti-Ro (SSA), affinity-purified anti-Ro (SSA) and serum depleted of anti-Ro (SSA) were prepared. After injection into human skin-grafted mice, purified anti-Ro (SSA) antibodies bound an antigen in the human skin graft, while preabsorbing anti-Ro (SSA) serum with Ro (SSA) virtually abolished binding to the human skin graft. Moreover, the pattern of IgG deposition was primarily epidermal and was identical in the human skin-grafted mice injected with purified anti-Ro (SSA) when compared with that found in five patients with subacute lupus (four adults, one neonate). These data directly show that anti-Ro (SSA) antibodies bind to the skin, and support the hypothesis that anti-Ro (SSA) autoantibodies are involved in the disease process that produces subacute cutaneous lupus and neonatal lupus.

Full text

PDF
1556

Images in this article

1558Image
on p.1558
1558Image
on p.1558
1558Image
on p.1558
1558Image
on p.1558
1559Image
on p.1559
1559Image
on p.1559
1559Image
on p.1559
1560Image
on p.1560
1561Image
on p.1561
1561Image
on p.1561

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aarden L. A., de Groot E. R., Feltkamp T. E. Immunology of DNA. III. Crithidia luciliae, a simple substrate for the determination of anti-dsDNA with the immunofluorescence technique. Ann N Y Acad Sci. 1975 Jun 30;254:505–515. doi: 10.1111/j.1749-6632.1975.tb29197.x. [DOI] [PubMed] [Google Scholar]
  2. BURNHAM T. K., NEBLETT T. R., FINE G. THE APPLICATION OF THE FLUORESCENT ANTIBODY TECHNIC TO THE INVESTIGATION OF LUPUS ERYTHEMATOSUS AND VARIOUS DERMATOSES. J Invest Dermatol. 1963 Dec;41:451–456. doi: 10.1038/jid.1963.140. [DOI] [PubMed] [Google Scholar]
  3. Bangert J. L., Freeman R. G., Sontheimer R. D., Gilliam J. N. Subacute cutaneous lupus erythematosus and discoid lupus erythematosus. Comparative histopathologic findings. Arch Dermatol. 1984 Mar;120(3):332–337. [PubMed] [Google Scholar]
  4. Bosma G. C., Custer R. P., Bosma M. J. A severe combined immunodeficiency mutation in the mouse. Nature. 1983 Feb 10;301(5900):527–530. doi: 10.1038/301527a0. [DOI] [PubMed] [Google Scholar]
  5. Gaither K. K., Fox O. F., Yamagata H., Mamula M. J., Reichlin M., Harley J. B. Implications of anti-Ro/Sjögren's syndrome A antigen autoantibody in normal sera for autoimmunity. J Clin Invest. 1987 Mar;79(3):841–846. doi: 10.1172/JCI112892. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Gilliam J. N., Sontheimer R. D. Distinctive cutaneous subsets in the spectrum of lupus erythematosus. J Am Acad Dermatol. 1981 Apr;4(4):471–475. doi: 10.1016/s0190-9622(81)80261-7. [DOI] [PubMed] [Google Scholar]
  7. Harley J. B., Yamagata H., Reichlin M. Anti-La/SSB antibody is present in some normal sera and is coincident with anti-Ro/SSA precipitins in systemic lupus erythematosus. J Rheumatol. 1984 Jun;11(3):309–314. [PubMed] [Google Scholar]
  8. Harrist T. J., Mihm M. C., Jr The specificity and clinical usefulness of the lupus band test. Arthritis Rheum. 1980 Apr;23(4):479–490. doi: 10.1002/art.1780230411. [DOI] [PubMed] [Google Scholar]
  9. Huff J. C., Weston W. L., Wanda K. D. Enhancement of specific immunofluorescent findings with use of a para-phenylenediamine mounting buffer. J Invest Dermatol. 1982 May;78(5):449–450. doi: 10.1111/1523-1747.ep12508101. [DOI] [PubMed] [Google Scholar]
  10. Jones S. K., Coulter S., Harmon C., Norris D. A., Rosandich M., Lee L. A. Ro/SSA antigen in human epidermis. Br J Dermatol. 1988 Mar;118(3):363–367. doi: 10.1111/j.1365-2133.1988.tb02429.x. [DOI] [PubMed] [Google Scholar]
  11. Jordon R. E. Lupus band test: clinical applications. Clin Dermatol. 1985 Jul-Sep;3(3):113–122. doi: 10.1016/0738-081x(85)90084-7. [DOI] [PubMed] [Google Scholar]
  12. Krueger G. G., Emam M. Biology of Langerhans cells: analysis by experiments to deplete Langerhans cells from human skin. J Invest Dermatol. 1984 Jun;82(6):613–617. doi: 10.1111/1523-1747.ep12261453. [DOI] [PubMed] [Google Scholar]
  13. LeFeber W. P., Norris D. A., Ryan S. R., Huff J. C., Lee L. A., Kubo M., Boyce S. T., Kotzin B. L., Weston W. L. Ultraviolet light induces binding of antibodies to selected nuclear antigens on cultured human keratinocytes. J Clin Invest. 1984 Oct;74(4):1545–1551. doi: 10.1172/JCI111569. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Lee L. A., Harmon C. E., Huff J. C., Norris D. A., Weston W. L. The demonstration of SS-A/Ro antigen in human fetal tissues and in neonatal and adult skin. J Invest Dermatol. 1985 Aug;85(2):143–146. doi: 10.1111/1523-1747.ep12276566. [DOI] [PubMed] [Google Scholar]
  15. Lee L. A., Lillis P. J., Fritz K. A., Huff J. C., Norris D. A., Weston W. L. Neonatal lupus syndrome in successive pregnancies. J Am Acad Dermatol. 1983 Sep;9(3):401–406. doi: 10.1016/s0190-9622(83)70149-0. [DOI] [PubMed] [Google Scholar]
  16. Lee L. A., Weston W. L., Krueger G. G., Emam M., Reichlin M., Stevens J. O., Surbrugg S. K., Vasil A., Norris D. A. An animal model of antibody binding in cutaneous lupus. Arthritis Rheum. 1986 Jun;29(6):782–788. doi: 10.1002/art.1780290612. [DOI] [PubMed] [Google Scholar]
  17. Lee L. A., Weston W. L. Lupus erythematosus in childhood. Dermatol Clin. 1986 Jan;4(1):151–160. [PubMed] [Google Scholar]
  18. Mamula M. J., Fox O. F., Yamagata H., Harley J. B. The Ro/SSA autoantigen as an immunogen. Some anti-Ro/SSA antibody binds IgG. J Exp Med. 1986 Dec 1;164(6):1889–1901. doi: 10.1084/jem.164.6.1889. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. McCune A. B., Weston W. L., Lee L. A. Maternal and fetal outcome in neonatal lupus erythematosus. Ann Intern Med. 1987 Apr;106(4):518–523. doi: 10.7326/0003-4819-106-4-518. [DOI] [PubMed] [Google Scholar]
  20. Provost T. T., Watson R., Gammon W. R., Radowsky M., Harley J. B., Reichlin M. The neonatal lupus syndrome associated with U1RNP (nRNP) antibodies. N Engl J Med. 1987 Apr 30;316(18):1135–1138. doi: 10.1056/NEJM198704303161807. [DOI] [PubMed] [Google Scholar]
  21. Sontheimer R. D., Maddison P. J., Reichlin M., Jordon R. E., Stastny P., Gilliam J. N. Serologic and HLA associations in subacute cutaneous lupus erythematosus, a clinical subset of lupus erythematosus. Ann Intern Med. 1982 Nov;97(5):664–671. doi: 10.7326/0003-4819-97-5-664. [DOI] [PubMed] [Google Scholar]
  22. Tan E. M., Cohen A. S., Fries J. F., Masi A. T., McShane D. J., Rothfield N. F., Schaller J. G., Talal N., Winchester R. J. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1982 Nov;25(11):1271–1277. doi: 10.1002/art.1780251101. [DOI] [PubMed] [Google Scholar]
  23. Weston W. L., Harmon C., Peebles C., Manchester D., Franco H. L., Huff J. C., Norris D. A. A serological marker for neonatal lupus erythematosus. Br J Dermatol. 1982 Oct;107(4):377–382. doi: 10.1111/j.1365-2133.1982.tb00380.x. [DOI] [PubMed] [Google Scholar]
  24. Yamagata H., Harley J. B., Reichlin M. Molecular properties of the Ro/SSA antigen and enzyme-linked immunosorbent assay for quantitation of antibody. J Clin Invest. 1984 Aug;74(2):625–633. doi: 10.1172/JCI111460. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES